DHRM [Dehaier Medical Systems] 8-K: (Original Filing)

[Dehaier Medical Announces Changes to Board of Directors BEIJING, November 28, 2011 /PRNewswire-Asia-FirstCall/ Dr. Yang has served as the Company’s vice president of sales and marketing since 2003. Dr. Yang was a sales director at Beijing Dehaier Technology Company Limited from 2001 through 2003. From 1996 to 1997, Dr. Yang was a product manager at Amtronix Inc., a medical equipment] [FORM 8-K CURRENT REPORT Date of report (date of earliest event reported): November 28, 2011 DEHAIER MEDICAL SYSTEMS LIMITED British Virgin Islands 001-34661 Not Applicable (State or Other Jurisdiction of Incorporation) (IRS Employer Identification No.) Room 908 East Plaza 15 West 4th Ring North Road Haidian District, Beijing 100195 People’s Republic of China +86 (10) 5166-0080 Not Applicable (Former name]

DHRM [Dehaier Medical Systems] 8-K: Dehaier Medical Announces Changes to Board of Directors

[Dehaier Medical Announces Changes to Board of Directors BEIJING, November 28, 2011 /PRNewswire-Asia-FirstCall/ Dr. Yang has served as the Company’s vice president of sales and marketing since 2003. Dr. Yang was a sales director at Beijing Dehaier Technology Company Limited from 2001 through 2003. From 1996 to 1997, Dr. Yang was a product manager at Amtronix Inc., a medical equipment] [FORM 8-K CURRENT REPORT Date of report (date of earliest event reported): November 28, 2011 DEHAIER MEDICAL SYSTEMS LIMITED British Virgin Islands 001-34661 Not Applicable (State or Other Jurisdiction of Incorporation) (IRS Employer Identification No.) Room 908 East Plaza 15 West 4th Ring North Road Haidian District, Beijing 100195 People’s Republic of China +86 (10) 5166-0080 Not Applicable (Former name]

DHRM [Dehaier Medical Systems] 10-Q: (Original Filing)

[FORM 10-Q x For the quarterly period ended September 30, 2011 ¨ For the transition period from Dehaier Medical Systems Limited British Virgin Islands Not Applicable (State or other jurisdiction of incorporation or organization) (I.R.S. employer identification number) Room 908, East Plaza 15 West 4th Ring North Road Haidian District, Beijing 100195 People’s Republic of China +86 (10) 5166 0080] [Party A: Beijing De-haier Technology Co. Ltd. (hereinafter referred as “Party A”) Party B: Beijing Dehaier Medical Technology Co., Ltd. (hereinafter referred as “Party B”) Party A and Party B have achieved mutual agreements on the following items: I Location 45 Yong An Road, Science Park, Changping District Beijing (102200) 1,800 Party A agrees to lease space at II Leasing] [Sales Agency Agreement 1. Contracting Parties Supplier hereinafter called “party A” IMD China Co., Ltd. Address: 1-2 Floor Building 12, No. 28 Yuhua Road, Area B. Beijing Tianzhu Airport Industrial Zone, Beijing China Agent hereinafter called “party B” Beijing DeHaier Medical Technology Co., Ltd. Address: 1223 Epoch Center 31 Zizhuyuan Road, Haidian District, Beijing, China IMD Beijing DeHaier to act] [Timesco of London Ltd Timesco House, 3 Carnival Park Carnival Close, Basildon Essex SS14 3WN, England T: +44 (0) 1268 297 700 F: +44 (0) 1268 297 800 info@timesco.com E: www.timesco.com INSTRUMENTS FOR LIFE Letter of Authorization th 10 Please treat this letter as authorization for Beijing De-Haier Medical Technology Co. Ltd to be a distributor for Timesco Laryngoscopes in] [Sales Agency Agreement Contracting Parties Supplier Agent (hereinafter called "party B"): Beijing DeHaier Medical Technology Co., Ltd. I General I. product distributor two of JMS Syringe pump & Infusion pump. Beijing DeHaier to act as JMS's 2. of According to different limits a. of p of General distributor: Party A authorizes Party B to distribute certain type or certain range] [Borrower: Beijing Dehaier Medical Technology Company Limited Lender: ICBC Beijing (Fangzhuang Branch) Purpose of Line of Credit 1. The purpose of the line of credit is to allow the Borrower to finance its working capital needs (including equipment purchases). Amount of Line of Credit 2. RMB10,000,000 Line of Credit Term 3. The line of credit shall run from June 20,] [Labor Contract Beijing Dehaier Medical Technology Company Limited Party A: Yanying Qi Party B: September 30, 2011 LABOR CONTRACT Beijing Dehaier Medical Technology Co. Ltd. (hereinafter referred to as “Party A”) and Name of Employee: Yanying Qi Identification Card No.: (hereinafter referred to as “Party B”) hereby execute this Contract in accordance with the applicable provisions of “The Labor Law] [Labor Contract Beijing Dehaier Medical Technology Company Limited Party A: Xiaoqing Wang Party B: July 8, 2011 LABOR CONTRACT Beijing Dehaier Medical Technology Co. Ltd. (hereinafter referred to as “Party A”) and Name of Employee: Xiaoqing Wang Identification Card No.: (hereinafter referred to as “Party B”) hereby execute this Contract in accordance with the applicable provisions of “The Labor Law] [I, Ping Chen, certify that: (1) I have reviewed this Form 10-Q of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [I, Yanying (Aileen) Qi, certify that: (1) I have reviewed this Form 10-Q of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Ping Chen Ping Chen] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Yanying (Aileen) Qi Yanying (Aileen) Qi Chief Financial Officer (Principal Financial Officer)]

DHRM [Dehaier Medical Systems] 10-Q: FORM 10-Q x For the quarterly period ended

[FORM 10-Q x For the quarterly period ended September 30, 2011 ¨ For the transition period from Dehaier Medical Systems Limited British Virgin Islands Not Applicable (State or other jurisdiction of incorporation or organization) (I.R.S. employer identification number) Room 908, East Plaza 15 West 4th Ring North Road Haidian District, Beijing 100195 People’s Republic of China +86 (10) 5166 0080] [Party A: Beijing De-haier Technology Co. Ltd. (hereinafter referred as “Party A”) Party B: Beijing Dehaier Medical Technology Co., Ltd. (hereinafter referred as “Party B”) Party A and Party B have achieved mutual agreements on the following items: I Location 45 Yong An Road, Science Park, Changping District Beijing (102200) 1,800 Party A agrees to lease space at II Leasing] [Sales Agency Agreement 1. Contracting Parties Supplier hereinafter called “party A” IMD China Co., Ltd. Address: 1-2 Floor Building 12, No. 28 Yuhua Road, Area B. Beijing Tianzhu Airport Industrial Zone, Beijing China Agent hereinafter called “party B” Beijing DeHaier Medical Technology Co., Ltd. Address: 1223 Epoch Center 31 Zizhuyuan Road, Haidian District, Beijing, China IMD Beijing DeHaier to act] [Timesco of London Ltd Timesco House, 3 Carnival Park Carnival Close, Basildon Essex SS14 3WN, England T: +44 (0) 1268 297 700 F: +44 (0) 1268 297 800 info@timesco.com E: www.timesco.com INSTRUMENTS FOR LIFE Letter of Authorization th 10 Please treat this letter as authorization for Beijing De-Haier Medical Technology Co. Ltd to be a distributor for Timesco Laryngoscopes in] [Sales Agency Agreement Contracting Parties Supplier Agent (hereinafter called "party B"): Beijing DeHaier Medical Technology Co., Ltd. I General I. product distributor two of JMS Syringe pump & Infusion pump. Beijing DeHaier to act as JMS's 2. of According to different limits a. of p of General distributor: Party A authorizes Party B to distribute certain type or certain range] [Borrower: Beijing Dehaier Medical Technology Company Limited Lender: ICBC Beijing (Fangzhuang Branch) Purpose of Line of Credit 1. The purpose of the line of credit is to allow the Borrower to finance its working capital needs (including equipment purchases). Amount of Line of Credit 2. RMB10,000,000 Line of Credit Term 3. The line of credit shall run from June 20,] [Labor Contract Beijing Dehaier Medical Technology Company Limited Party A: Yanying Qi Party B: September 30, 2011 LABOR CONTRACT Beijing Dehaier Medical Technology Co. Ltd. (hereinafter referred to as “Party A”) and Name of Employee: Yanying Qi Identification Card No.: (hereinafter referred to as “Party B”) hereby execute this Contract in accordance with the applicable provisions of “The Labor Law] [Labor Contract Beijing Dehaier Medical Technology Company Limited Party A: Xiaoqing Wang Party B: July 8, 2011 LABOR CONTRACT Beijing Dehaier Medical Technology Co. Ltd. (hereinafter referred to as “Party A”) and Name of Employee: Xiaoqing Wang Identification Card No.: (hereinafter referred to as “Party B”) hereby execute this Contract in accordance with the applicable provisions of “The Labor Law] [I, Ping Chen, certify that: (1) I have reviewed this Form 10-Q of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [I, Yanying (Aileen) Qi, certify that: (1) I have reviewed this Form 10-Q of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Ping Chen Ping Chen] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Yanying (Aileen) Qi Yanying (Aileen) Qi Chief Financial Officer (Principal Financial Officer)]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Third Quarter 2011 Financial Results Shenzhen, China – November 7, 2011 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September 30, 2011. Highlights for Third Quarter 2011 - Net revenues were $218.4 million, up 29.8% over the] [Mindray Announces Up to $100 Million Share Repurchase Program Shenzhen, China – November 7, 2011 – Mindray Medical International Limited (“Mindray” or “Company”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved a share repurchase program. The share repurchase program is authorized to be in effect through December]

MR [Mindray Medical International] 6-K: Mindray Announces Third Quarter 2011 Financial Results Shenzhen,

[Mindray Announces Third Quarter 2011 Financial Results Shenzhen, China – November 7, 2011 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September 30, 2011. Highlights for Third Quarter 2011 - Net revenues were $218.4 million, up 29.8% over the] [Mindray Announces Up to $100 Million Share Repurchase Program Shenzhen, China – November 7, 2011 – Mindray Medical International Limited (“Mindray” or “Company”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved a share repurchase program. The share repurchase program is authorized to be in effect through December]

By | 2016-03-04T08:22:58+00:00 November 7th, 2011|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Third Quarter 2011 Financial Results STYLE="font-family:Times New Roman" SIZE="2"> Shenzhen, China November7, 2011 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September30, 2011. Highlights for Third Quarter 2011 -] [STYLE="font-family:Times New Roman" SIZE="2"> Mindray Announces Up to $100 Million Share Repurchase Program Shenzhen, China November7, 2011 Mindray Medical International Limited (Mindray ormpany, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved a share repurchase program. The share repurchase program is authorized to]

MR [Mindray Medical International] 6-K: Mindray Announces Third Quarter 2011 Financial Results STYLE=”font-family:Times

[Mindray Announces Third Quarter 2011 Financial Results STYLE="font-family:Times New Roman" SIZE="2"> Shenzhen, China November7, 2011 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September30, 2011. Highlights for Third Quarter 2011 -] [STYLE="font-family:Times New Roman" SIZE="2"> Mindray Announces Up to $100 Million Share Repurchase Program Shenzhen, China November7, 2011 Mindray Medical International Limited (Mindray ormpany, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved a share repurchase program. The share repurchase program is authorized to]

By | 2016-02-08T05:35:38+00:00 November 7th, 2011|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments

MR [Mindray Medical International] 6-K: Mindray Announces Third Quarter 2011 Financial Results Shenzhen,

[Mindray Announces Third Quarter 2011 Financial Results Shenzhen, China November7, 2011 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September30, 2011. Highlights for Third Quarter 2011 - Net revenues were $218.4 million, up 29.8% over] [Mindray Announces Up to $100 Million Share Repurchase Program Shenzhen, China November7, 2011 Mindray Medical International Limited (Mindray ormpany, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved a share repurchase program. The share repurchase program is authorized to be in effect through]

By | 2016-01-13T11:02:31+00:00 November 7th, 2011|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments

DHRM [Dehaier Medical Systems] 8-K: (Original Filing)

[Dehaier Medical Appoints Interim Chief Financial Officer BEIJING, Sept. 30, 2011 /PRNewswire-Asia-FirstCall/ — Dehaier Medical (NASDAQ: DHRM) an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that Aileen Qi has been appointed interim Chief Financial Officer, effective October 1, 2011. Ms. Rita Liu has tendered her resignation as] [ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. Item 5.02(b) Ms. Rita Liu has tendered her resignation as the Chief Financial Officer of Dehaier Medical Systems Limited (the “Company”), effective September 30, 2011. Ms. Liu resigned in order to pursue other professional opportunities, and not due to any]

Skip to toolbar